JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Berger
    Berger
  2. Drilon
    Drilon
  3. Mandelker
    Mandelker
  4. Offit
    Offit
  5. Shia
    Shia
  6. Stadler
    Stadler
  7. Bandlamudi
    Bandlamudi
  8. Carlo
    Carlo
  9. Cercek Hanjis
    Cercek Hanjis
  10. Do
    Do

Groups

  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Graduate Medical Education (10)
  4. Department of Pathology and Laboratory Medicine (9)
  5. Epidemiology and Biostatistics (7)
  6. GSK Faculty (7)
  7. Weinberg Fellows (7)
  8. Biostatistics Service (6)
  9. Center for Pancreatic Cancer Research (6)
  10. GME, Medicine (6)
Search Within
  1. "2023"
Formats
  1. Journal Article (17)
  2. Correspondence (1)
  3. Review (1)
Groups
  1. Department of Medicine (11)
  2. Solid Tumor Oncology Division (11)
  3. Graduate Medical Education (10)
  4. Department of Pathology and Laboratory Medicine (9)
  5. Epidemiology and Biostatistics (7)
  6. GSK Faculty (7)

More Groups

People
  1. Michael Berger (4)
  2. Alexander Drilon (3)
  3. Diana Mandelker (3)
  4. Jinru Shia (3)
  5. Kenneth Offit (3)
  6. Zsofia Stadler (3)

More People

Years
  1. 2023 (19)
Publishers
  1. American Society of Clinical Oncology (19)

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Complete remission of widely metastatic human epidermal growth factor receptor 2-amplified pancreatic adenocarcinoma after precision immune and targeted therapy with description of sequencing and organoid correlates
    Journal Article

    King, D. A.; Smith, A. R.; Pineda, G.; Nakano, M.; Michelini, F.; Goedegebuure, S. P.; Thyparambil, S.; Liao, W. L.; McCormick, A.; Ju, J. H.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Important considerations for real-world analysis of neurotrophic tyrosine receptor kinase fusion cancer and tropomyosin receptor kinase inhibitors
    Correspondence

    Brose, M. S.; Hong, D. S.; Drilon, A.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Amplification of wild-type RET represents a novel molecular subtype of several cancer types with clinical response to selpercatinib
    Journal Article

    Gandhi, M. M.; Ricciuti, B.; Harada, G.; Repetto, M.; Gildenberg, M. S.; Singh, A.; Li, Y. Y.; Gagné, A.; Wang, X.; Aizer, A.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Associations between cancer predisposition mutations and clonal hematopoiesis in patients with solid tumors
    Journal Article

    Franch-Expósito, S.; Mehine, M.; Ptashkin, R. N.; Bolton, K. L.; Bandlamudi, C.; Srinivasan, P.; Zhang, L.; Goodell, M. A.; Gedvilaite, E.; Menghrajani, K.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Response to repotrectinib after development of NTRK resistance mutations on first- and second-generation TRK inhibitors
    Journal Article

    Chen, M. F.; Yang, S. R.; Shia, J.; Girshman, J.; Punn, S.; Wilhelm, C.; Kris, M. G.; Cocco, E.; Drilon, A.; Raj, N.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer
    Journal Article

    Sia, T. Y.; Maio, A.; Kemel, Y. M.; Arora, K. S.; Gordhandas, S. B.; Kahn, R. M.; Salo-Mullen, E. E.; Sheehan, M. A.; Tejada, P. R.; Bandlamudi, C.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Prevalence and clinical implications of mismatch repair-proficient colorectal cancer in patients with Lynch syndrome
    Journal Article

    Ranganathan, M.; Sacca, R. E.; Trottier, M.; Maio, A.; Kemel, Y.; Salo-Mullen, E.; Catchings, A.; Kane, S.; Wang, C.; Ravichandran, V.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Anaplastic lymphoma kinase inhibitors for therapy of neuroblastoma in adults
    Journal Article

    Stiefel, J.; Kushner, B. H.; Roberts, S. S.; Iglesias-Cardenas, F.; Kramer, K.; Modak, S.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Phase IIa study of PLX2853 in gynecologic cancers with known ARID1A mutation and phase Ib/IIa study of PLX2853/carboplatin in platinum-resistant epithelial ovarian cancer
    Journal Article

    Duska, L. R.; Zamarin, D.; Hamilton, E.; Oza, A.; Fleming, G.; Spira, A.; Yeku, O. O.; Richardson, D. L.; Walling, J.; Inokuchi, K.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology